erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.
over years of research, scientists discovered that cgrp helps transmit pain signals in the brain..
..
“contrary to public belief, the majority of claims are paid out and scottish widows should be proud of how many families they helped during such challenging times.”..